Cyclotron-based gallium-68 generator breaks production records

26 Nov 2019 Tami Freeman Gallium-68 (68Ga) is a positron emitter that’s becoming established as a valuable diagnostic isotope, primarily for detection of neuroendocrine tumours (NETs). Such tumours do not metabolize glucose well – precluding their visualization via standard FDG-PET scans – but overexpress somatostatin receptors that bind, for example, to the PET agent 68Ga-Dotatate. […]

Competition heats up to produce medical radioisotope

15 Nov 2019 David Kramer Two North American companies hope their novel production processes for technetium-99m give them a leg up in an increasingly crowded market. The global supply chain for the world’s most-used radioisotope, the medical imaging tracer technetium-99m, is notoriously unreliable. When one or more of the handful of reactors producing 99mTc’s parent isotope, molybdenum-99, […]

ARTMS/Odense University Hospital to Present Solid Target Gallium-68 Production Record at European Association of Nuclear Medicine

Found and Chief Technology Officer, Dr. Paul Schaffer, of ARTMS Products Inc., Vancouver, British Columbia – October 10, 2019 – Utilizing the ARTMS QUANTM Irradiation System (QISTM) and collaborating with scientists and clinical researchers from the Odense University Hospital (OUH) and the University of Southern Denmark, ARTMS Products Inc, has demonstrated record gallium-68 (68Ga) production […]

Chuck Conroy Appointed CEO of ARTMS

Charles S. Conroy Chief Executive Officer of ARTMS Products Inc., Vancouver, British Columbia – September 10, 2019 – ARTMS Products Inc., the global leader in the innovation and commercialization of novel technologies that enable cyclotron production of the world’s most needed medical radioisotopes, is pleased to announce the appointment of Charles S. Conroy R.Ph, MBA as […]

ARTMS’ QUANTM Irradiation SystemTM to be featured at two international conferences in September

ARTMS invited presentations in September Vancouver, September 24, 2018 /BusinessWire/ — ARTMS Products, Inc. announced today that it has been invited to present at the National Nuclear Security Administration’s 2018 Mo-99 Topical Meeting on Tuesday, September 25th and the Third International Symposium on Technetium and other Radiometals in Chemistry and Medicine on Thursday, September 27th. Lead […]

QUANTM Irradiation System™ Earns CE Mark Approval

First-in-class, advanced technology enables production of high-value radioisotopes on medical cyclotrons VANCOUVER, August 8, 2018 — ARTMS Products today announced it received CE marking approval for its first-in-class, advanced technology QUANTM Irradiation System TM for producing high-value radioisotopes, such as Tc-99m and Ga-68, on medical cyclotrons. Cyclotron facilities are constantly facing higher isotope costs and […]

ARTMS Products Inc. Raises US$3 Million to Advance a Safe Alternative Way to Locally Produce Medical Isotopes and Avoid Future Supply Distruptions

Vancouver, British Columbia. – December 18, 2017 – Today, ARTMS Products Inc., the leader in the development of novel technologies which enable the production of the world’s most-used diagnostic imaging isotope, announced it has raised US$3 million.  The investment comes from Quark Venture Inc. and GF Securities, through their Global Health Science Fund, which invests […]

ARTMS Products Inc. and GE Healthcare Team up to Expand Cyclotron Produced Radioisotopes and Address Longstanding Radiopharmaceutical Supply Concerns in Medical Imaging

Today, ARTMS Products, Inc. announced they have signed a strategic partnership with GE Healthcare around ARTMS’ proprietary QUANTM99TM Irradiation System (QISTM) for radioisotope production. The goal of the partnership is to supply equipment, technologies and research that supports the production and processing of radioisotopes on GE’s PETtraceTM 800 platform of medical cyclotrons. The QISTM integrates […]

ARTMS Products Inc. Honoured with ‘Most Promising Pre-Commercial Technology’ Award at BC Technology Impact Awards

ARTMS Products, Inc., a Vancouver-based medical technology company, has won ‘Most Promising Pre-Commercial Technology’ at the BC Tech Technology Impact Awards recently held in Vancouver. Chosen from a very competitive pool of companies from diverse areas of industry, this distinction is granted to the company poised to drive fundamental change in their industry within the […]